
Through non-invasive brainwave sensing and artificial intelligence recognition technology, the system can interpret the patient's movement intentions and control the exoskeleton to assist in lower limb rehabilitation training. The average brain control recognition accuracy measured by Taichung Rongzhong is 92.5%.
AI-generated summary
With the support of the Industrial Technology Department of the Ministry of Economic Affairs, ITRI developed a brainwave-controlled exoskeleton rehabilitation system and cooperated with many universities and hospitals for clinical verification.
Through non-invasive brainwave sensing and artificial intelligence recognition technology, the system can interpret the patient's movement intentions and control the exoskeleton to assist in lower limb rehabilitation training.
In order to improve the quality and efficiency of rehabilitation for stroke patients, ITRI, with the support of the Industrial Technology Department of the Ministry of Economic Affairs, joined hands with National Yang-Ming Chiao Tung University and National Taiwan University to develop a "brain wave controlled exoskeleton rehabilitation system", and collaborated with Taichung Veterans General Hospital and Kaohsiung Medical University Chung Ho Memorial Hospital for clinical verification. Through non-invasive brainwave sensing and artificial intelligence recognition technology, the system can interpret the patient's movement intentions and control the exoskeleton to assist in lower limb rehabilitation training. Among them, the average brain control recognition accuracy measured by stroke patients in Taichung Rongzong reached 92.5%, demonstrating the potential of brain wave control technology in neurological rehabilitation.
Zheng Boxun, director of ITRI's Service System Technology Center, said that traditional exoskeleton rehabilitation equipment mainly assists patient training through preset movement patterns. The brainwave-controlled exoskeleton rehabilitation system developed by ITRI further combines brainwave recognition technology to allow patients to participate in the rehabilitation process through movement intentions. This technology was developed by Ke Liwei, chief technology officer of the Service System Technology Center of ITRI and professor of the Electrical Engineering Department of Yang-Ming National Chiao Tung University. He introduced a self-developed non-invasive brainwave sensing device and recognition algorithm into the system, using a graphene dry electrode brainwave cap to capture signals, identify the user's movement intention, and then control the exoskeleton's auxiliary movements.
In order to improve the efficiency of brainwave signal processing, the team also collaborated with Professor Yang Jiaxiang of the Department of Electrical Engineering and Institute of Electronic Engineering of National Taiwan University to convert the brainwave recognition algorithm originally executed by software into a hardware-accelerated design and complete functional verification through a programmable chip (FPGA). Test results show that the computing performance is 76 times higher than that of traditional computer processors, which helps shorten brainwave signal processing time and improve the real-time control of exoskeleton movements.
In terms of clinical verification, after patients wear brainwave sensing devices and lower limb exoskeletons, the system can analyze brainwave signals, identify movement intentions, and then control the exoskeleton to assist in completing rehabilitation training. With the assistance of Cheng Yuanyang, director of the Rehabilitation Department of Taichung Veterans General Hospital, the team has completed training and testing on stroke inpatients, with an average brain control recognition accuracy of 92.5%. In addition, the team also collaborated with Chen Jiaxin, a physician at the Department of Rehabilitation, Chung Ho Memorial Hospital, Kaohsiung Medical University, to conduct clinical trials to continuously evaluate the feasibility of the system in neurological rehabilitation.
In terms of industrialization, ITRI cooperates with domestic players such as Fubao Technology and Fubao Biomedical to promote lightweight smart rehabilitation equipment and autonomous wearable applications. At present, the team has completed the trial production of brainwave signal processing chips using a 40-nanometer process. Subsequently, they will conduct chip function testing and mass production planning, and will cooperate with industry players to establish a quality management system. They will follow the relevant regulations and product verification procedures of the Food and Drug Administration of the Ministry of Health and Welfare, gradually promote the commercialization of the technology, and promote the development of Taiwan's smart medical and rehabilitation assistive device industry.
AI outlook — possibilities, not facts
Conduct chip functional testing and mass production planning and promote productization in compliance with regulations
Very likely · Within months

The World Health Organization reports over 3,000 cholera deaths globally in the first nine months of 2026, with nearly 90 percent occurring in Africa. Despite the toll, the WHO maintains its goal of reducing global cholera cases by 90 percent by 2030.

The National Health Commission has teamed up with multiple departments to strengthen monitoring and response to shortage drug information through a linkage mechanism. Focusing on the problem of insufficient supply of cyclophosphamide for injection, efforts have been made to ensure the clinical drug needs of the public through measures such as increasing production capacity, online procurement, and circulation reserves.

The US FDA issued a warning stating that GLP-1 receptor agonists may increase the risk of rare ischemic optic neuropathy (NAION). Taiwan's Food and Drug Administration stated that it would initiate a re-evaluation of the safety of this type of drugs and reminded the public that they should be used after evaluation by a physician and never purchase drugs from unknown sources.

The 9th China International Import Expo concluded in Shanghai. The popularity of the pharmaceutical and health sector continues to grow, with intensive global launches of innovative drugs and devices, China’s independently developed innovative drugs appearing, and multi-party collaborative health science popularization activities being launched one after another.

Officials from China's National Development and Reform Commission said on the 10th that this year the central government will invest more than 20 billion yuan to transform 20,000 wards with four or more people into rooms with two or three people, and continue to promote the construction of a close county medical community and a rehabilitation and nursing service system.

A study analyzing nearly 12,000 patients found that the incidence of stroke between 6 a.m. and noon was nearly 80% higher than at other times. Experts pointed out that this is related to the increase in blood pressure and blood coagulation status, and called on to pay attention to the signs of stroke through the B.E.F.A.S.T. formula.